geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Genetically determined variability in mental and emotional development


, : Genetically determined variability in mental and emotional development. Klinische Wochenschrift 59(17): 1009-1018

Human beings develop in biologically determined phases: During certain periods of life, sensitivity for learning specific tasks is increased. For successful completion of the learning process, however, adequate offers from the environment are necessary. Within the limits of this general rule, considerable genetically determined, interindividual differences are observed. The ability to develop faster or slower in certain phases of life, - strong and weak points, - specific chances and liabilities are distributed unevenly. The art of education consists in adjusting offers for learning to these individual differences. In addition to the cognitive field, requirements for emotional and social learning should not be neglected. Research on biologic maturation, on its interaction with offers from the environment, and on genetic variability will have to include in future increasingly neurobiologic concepts and methods.

US$29.90

PMID: 7289439


Other references

Vasić, V., 1969: Postextrasystolic phenomenon in clinical practice--especially in young persons with signs of neurocirculatory dystonia. Medicinski Glasnik 23(5): 83-88

Singh Naz N.; Rodriguez W.J.; Kidd A.H.; Brandt C.D., 1988: Monoclonal antibody elisa for specific identification and typing of subgroup f adenoviruses. Monoclonal antibody specific for subgroup F enteric adenoviruses (EAds) was prepared by fusing P3-NS1/Ag4-1 mouse myeloma cells with lymphocytes from BALB/c mice immunized with G1105, an adenovirus type 41 (Ad41) strain. Monoclone 3F11/2H9, which...

Fanciulli, M.; Bruno, T.; Giovannelli, A.; Gentile, F.P.; D.P.dova, M.; Rubiu, O.; Floridi, A., 2000: Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine. The relationship between modification of energy metabolism and extent of drug resistance was investigated in two sublines (LoVoDX and LoVoDX10) from human LoVo colon carcinoma cells that exhibit different degrees of resistance to doxorubicin. Resu...

Graber, P., 1978: The curative treatment of prostatic carcinoma. Therapeutische Umschau. Revue Therapeutique 35(10): 845-848

Noonan, K.L.; North, S.; Bitting, R.L.; Armstrong, A.J.; Ellard, S.L.; Chi, K.N., 2013: Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide. Abiraterone acetate and enzalutamide both improve outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC). Optimal sequencing for these agents and whether cross-resistance occurs is unknown. Multicentre review of patients...

Orzada, S.; Maderwald, S.; Poser, B.Andreas.; Bitz, A.K.; Quick, H.H.; Ladd, M.E., 2011: RF excitation using time interleaved acquisition of modes (TIAMO) to address B1 inhomogeneity in high-field MRI. As the field strength and, therefore, the operational frequency in MRI is increased, the wavelength approaches the size of the human head/body, resulting in wave effects, which cause signal decreases and dropouts. Several multichannel approaches h...

Stewart, T.; Stromberg, B.; Lawhorn, D., 1993: Internal parasites in swine. Pork industry handbook: (44,rev) 1-5

Anonymous, 1982: Earth pyramids. Kosmos (Stuttgart) 78(1): 14-15

Chernysh V.G.; Bocharova N.N., 1971: Changes in the oxidation reduction potential and proteolytic activity of bakers yeasts during storage. Prikladnaya Biokhimiya i Mikrobiologiya 7(4): 429-433

Luxon, B.A.; Grace, M.; Brassard, D.; Bordens, R., 2002: Pegylated interferons for the treatment of chronic hepatitis C infection. Background: Interferon (IFN) alfa is a clinically effective therapy used in a wide range of viral infections and cell-proliferative disorders. Combination therapy with IFN alfa-2b and ribavirin is the current standard of care for the treatment of...